References
1. Flécher E, Anselmi A, Corbineau H, Langanay T, Verhoye JP, Félix C,
et al. Current aspects of extracorporeal membrane oxygenation in a
tertiary referral centre: Determinants of survival at follow-up. Eur J
Cardio-thoracic Surg. 2014;46(4):665–71.
2. Beckmann A, Benk C, Beyersdorf F, Haimerl G, Merkle F, Mestres C, et
al. Position article for the use of extracorporeal life support in adult
patients. Eur J Cardio-thoracic Surg. 2011;40(3):676–80.
3. Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et
al. Predicting survival after ECMO for refractory cardiogenic shock: The
survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J.
2015;36(33):2246–56.
4. Daou O, Winiszewski H, Besch G, Pili-floury S, Belon F, Guillon B, et
al. Initial pH and shockable rhythm are associated with favorable
neurological outcome in cardiac arrest patients resuscitated with
extracorporeal cardiopulmonary resuscitation. J Thorac Dis.
2020;12(3):849–57.
5. Okada Y, Kiguchi T, Irisawa T, Yoshiya K, Yamada T, Hayakawa K.
Association between low pH and unfavorable neurological outcome among
out-of-hospital cardiac arrest patients treated by extracorporeal CPR :
a prospective observational cohort study in Japan. J intensive care.
2020;1–9.
6. Seeger FH, Toenne M, Lehmann R, Ehrlich JR. Simplistic approach to
prognosis after cardiopulmonary resuscitation — value of pH and
lactate. J Crit Care [Internet]. 2013;28(3):317.e13-317.e20.
Available from: http://dx.doi.org/10.1016/j.jcrc.2012.05.004
7. Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray
TA, et al. Advanced reperfusion strategies for patients with out-of-
hospital cardiac arrest and refractory ventricular fibrillation ( ARREST
): a phase 2 , single centre , open-label , randomised controlled trial.
Lancet [Internet]. 2020;6736(20):1–10. Available from:
http://dx.doi.org/10.1016/S0140-6736(20)32338-2
8. Mørk SR, Stengaard C, Linde L, Møller JE, Jensen LO, Schmidt H, et
al. Mechanical circulatory support for refractory out ‑ of ‑ hospital
cardiac arrest : a Danish nationwide multicenter study. Crit Care.
2021;1–13.
9. Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et
al. The ENCOURAGE mortality risk score and analysis of long-term
outcomes after VA-ECMO for acute myocardial infarction with cardiogenic
shock. Intensive Care Med. 2016;42(3):370–8.
10. Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA,
Fortenberry JD, et al. Extracorporeal Life Support Organization Registry
International Report 2016. ASAIO J. 2017;63(1):60–7.
11. Mungan I, Kazancl D, Bektaş Ş, Ademoglu D, Turan S. Does lactate
clearance prognosticates outcomes in ECMO therapy: A retrospective
observational study. BMC Anesthesiol. 2018;18(1):1–8.
12. Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic
behavior of lactate is linked to mortality in postcardiotomy patients
with extracorporeal membrane oxygenation support: A retrospective
observational study. J Thorac Cardiovasc Surg [Internet].
2015;149(5):1445–50. Available from:
http://dx.doi.org/10.1016/j.jtcvs.2014.11.052